About this source
- Kind
- Research
- Design
- Human clinical trial
- Population
- Human healthy adult men
- Sample size
- 9
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Phase I pharmacokinetic study: it measures how fast the peptide leaves the blood, not any effect on health. Nine men. Unusual concentration spikes in four of nine subjects were noted by the authors.
Cited in
Phase I pharmacokinetics, nine men
GHRP-6 · Research finding
Limited
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.